AVIATION INNOVATIONS AND RESEARCH, INC. (AVRI) Announces Name Change, Acquisition of ITG, Inc., and Reverse Stock Split
October 26 2004 - 10:01AM
PR Newswire (US)
AVIATION INNOVATIONS AND RESEARCH, INC. (AVRI) Announces Name
Change, Acquisition of ITG, Inc., and Reverse Stock Split LAS
VEGAS, Oct. 26 /PRNewswire-FirstCall/ -- AVIATION INNOVATIONS AND
RESEARCH, INC. (OTC:AVRI) today announced that the company has
effectuated a 1:15 reverse stock split and has changed its
Corporate Name to IMMUNE-TREE INTERNATIONAL, INC. (OTC:IMUT) In a
newly planned direction of Corporate Strategy, the Company also
announced that it has completed the purchase of 100% of the
outstanding shares of ITG, Inc., a Utah based Corporation. ITG will
become a wholly-owned subsidiary of IMMUNE-TREE INTERNATIONAL, INC.
IMMUNE-TREE INTERNATIONAL, INC. is a nutritional manufacturing
company with far reaching experience and success in multiple areas.
It has researched, formulated, manufactured, sold and monitored the
success of nutritional supplements to balance and strengthen the
body systems. IMMUNE- TREE INTERNATIONAL, INC. has formulated 12
different supplements. IMMUNE-TREE INTERNATIONAL, INC. has, as its
major focus in research; anti- aging, immune enhancement and inch
loss management. Their products are currently welcomed in the
United States, Malaysia, Korea, Australia, with requests for
admittance to Japan, India, Mexico and numerous other countries.
IMMUNE-TREE INTERNATIONAL, INC. also stated that it is actively
pursuing other acquisitions that would enhance the companies' new
direction. For further information, please contact Dr. Anthony
Kleinsmith at 801-434-8129 or visit our web site at
www.immunetree.com. CAUTIONARY STATEMENT: No stock exchange,
securities commission or other regulatory authority has approved or
disapproved the information contained herein. The New Release
includes certain "forward-looking statements." All statements other
than statements of historical fact included in this release are
forward-looking statements that involve various risks and
uncertainties. There can be no assurance that such factors that
could cause actual results to differ materially from the Company's
expectations are exploration risks detailed herein and from time to
time in the filing made by the Company with securities regulators.
Penny stock investments are risky, with no guarantees of market for
the securities. Investors are cautioned to proceed only after
obtaining advice from investment professionals. DATASOURCE:
IMMUNE-TREE INTERNATIONAL, INC. CONTACT: Dr. Anthony Kleinsmith of
IMMUNE-TREE, +1-801-434-8129 Web site: http://www.immunetree.com/
Copyright